C88.41

C88.41: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission

Billable / specific codeICD-10-CM

C88.41 is a billable, specific ICD-10-CM code for extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma], in remission. It is valid for submission on a claim.

Check C88.41 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above C88.41

A category’s note binds every code beneath it.

Written on C88.4: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

high malignant (diffuse large B-cell) lymphoma (C83.3-)

Written on C88: Malignant immunoproliferative diseases and certain other B-cell lymphomas

B-cell lymphoma, unspecified (C85.1-)
personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)

Risk adjustment

C88.41 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 21 Lymphoma and Other Cancers0.671 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C88.41 is named in 29 Medicare coverage policies: 29 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A55717Billing and Coding: Lab: Flow Cytometry
A56380Billing and Coding: Rituximab

Code history

addedFY2024-FY2027
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission

Other codes under C88.4

C88.40Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission